Immunostaining of p16INK4a/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases

International Journal of Medical Sciences

Volumn 10, Issue 12, 2013, Pages 1602-1607

  Byun, Seung Won ^a   Lee, Ahwon ^a   Kim, Suyeon ^a   Choi, Yeong Jin ^a   Lee, Youn Soo ^a   Park, Jong Sup ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cervicovaginal cytology; HPV DNA typing; Human papillomavirus; Immunocytochemistry; L1 capsid protein; p16 INK4a Ki 67 dual staining

Indexed keywords

CAPSID PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; KI 67 ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DNA FINGERPRINTING; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

CERVICOVAGINAL CYTOLOGY; HPV DNA TYPING.; HUMAN PAPILLOMAVIRUS; IMMUNOCYTOCHEMISTRY; L1 CAPSID PROTEIN; P16 INK4A/KI-67 DUAL STAINING;

ADULT; AGED; AGED, 80 AND OVER; CAPSID PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTODIAGNOSIS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; PREGNANCY; TUMOR MARKERS, BIOLOGICAL; VAGINAL SMEARS;

EID: 84884467288     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6526     Document Type: Article

References (17)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594-606.
2. Denny L. The prevention of cervical cancer in developing countries. BJOG. 2005; 112:1204-12.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
4. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107:S2-5.
5. Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186-92.
6. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-99.
7. Elsheikh TM, Kirkpatrick JL, Wu HH. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in papanicolaou tests. Cancer. 2006;25:277-81.
8. Yoshida T, Sano T, Kanuma T, et al. Usefulness of CINtec® PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer. Acta Cytol. 2011;55:413-20.
9. Huang MZ, Li HB, Nie XM, et al. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Diagn Cytopathol. 2010;38:573-8.
10. Choi JJ, Kim C, Park H. Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses. J Clin Microbiol. 2009;47:1785-90.
11. Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J. 2005;46:597-613.
12. Sahebali S, Depuydt CE, Segers K, et al. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? J Clin Pathol. 2003;56:681-6.
13. Donà MG, Vocaturo A, Giuliani M, et al. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, human papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Oncol. 2012;126:198-202.
14. Petry KU, Schmidt D, Scherbring S, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology. Gynecol Oncol. 2011;121:505-9.
15. Schmidt D, Bergeron C, Denton KJ, Ridder R. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol. 2011;119:158-66.
16. Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations. Diagn Cytopathol. 2013;41:35-40.
17. Hilfrich R, Hariri J. Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker. Anal Quant Cytol Histol. 2008;30:78-82.